3 Small-Cap Stocks to Buy Before May 15
Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call Transcript
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Nautilus Biotechnology, Inc. (NAUT) Q4 2025 Earnings Call Transcript
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
Nautilus Biotechnology, Inc. (NAUT) Q3 2025 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NAUT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Nautilus Biotechnology, Inc. (NAUT) Q2 2025 Earnings Conference Call Transcript
Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025
26,324 Shares in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Purchased by Squarepoint Ops LLC
Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call Transcript
Nautilus: Trading Below An Albeit Lower Net Cash Figure
Nautilus Biotechnology, Inc. (NAUT) Q4 2024 Earnings Call Transcript
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
Nautilus Biotechnology, Inc. (NAUT) Q3 2024 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
Nautilus Biotechnology (NAUT) Upgraded to Buy: Here's What You Should Know
Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript
Nautilus Biotechnology Reports First Quarter 2024 Financial Results
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award
Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development
Nautilus Biotechnology, Inc. (NAUT) Q3 2023 Earnings Call Transcript
Nautilus Biotechnology Reports Third Quarter 2023 Financial Results
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
Nautilus Biotechnology to Participate in Upcoming August Investor Conferences
Nautilus Biotechnology, Inc. (NAUT) Q2 2023 Earnings Call Transcript
Nautilus Biotechnology Reports Second Quarter 2023 Financial Results
Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023
Nautilus Biotechnology to Participate in Upcoming June Investor Conferences
Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023
Nautilus Biotechnology to Participate in B. Riley Securities' Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference
3 Penny Stocks Under $3 To Watch In March
Nautilus Biotechnology, Inc. (NAUT) Q4 2022 Earnings Call Transcript
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
Nautilus Biotechnology, Inc. (NAUT) Q3 2022 Earnings Call Transcript
Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference